Sanofi Q3 2018 Performance Confirms Return to Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Sanofi (SNY) Tops Q2 EPS by EUR 0.14
October 31, 2018 6:24 AM EDTSanofi (NYSE: SNY) reported Q2 EPS of EUR1.84, EUR0.14 better than the analyst estimate of EUR1.70. Revenue for the quarter came in at EUR9.39 billion versus the consensus estimate of EUR9.26 billion.
For earnings history and earnings-related data on Sanofi (SNY) click here.
... More